Skip to content
Screener

GeneDx Holdings WGS Q1 2026 earnings

Reported May 4, 2026 · After market close

Revenue$102.3MMiss by $10.2M
EPS-$0.28Miss by $0.22
Revenue estimate$112.5M
EPS estimate-$0.06

Next report

Oct 27, 2026 (in a month)
Revenue estimate$123.0M
EPS estimate$0.07

Financials

Q1 2026

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.88B-24.3%
Enterprise value$1.88B-22.8%
P/S4.2×-3.3×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%—
Net margin-17.6%—

Returns & leverage

See full
Return on equity-30.4%—
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

FAQ

When did GeneDx Holdings report Q1 2026 earnings?
GeneDx Holdings (WGS) reported Q1 2026 earnings on May 4, 2026 after market close.
What were GeneDx Holdings's Q1 2026 revenue and EPS?
GeneDx Holdings reported revenue of $102.3M and eps of $-0.28 for Q1 2026.
Did GeneDx Holdings beat estimates in Q1 2026?
Revenue missed the consensus estimate of $112.5M by $10.2M. EPS missed the consensus estimate of $-0.06 by $0.22.
How did GeneDx Holdings's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 17.4% from $87.1M a year earlier.
Where can I find GeneDx Holdings's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001818331-26-000039) and the 10-Q periodic report (0001818331-26-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.